Drug Trial Radar · NCT04285086
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
Last checked: Nov 20, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
174
Actual
Start
Aug 25, 2020
Primary completion
Nov 12, 2024
Study completion Aug 31, 2029
Sponsor
- Lead sponsor
- PharmaEssentiaIndustry
- Sponsor type
- Industry
- First posted
- Feb 26, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 3 open-label, multicenter, randomized, active-controlled study designed to compare the efficacy and safety and tolerability of P1101 compared with ANA after 12 months of treatment as second-line therapy for subjects with ET who have had a suboptimal or failed response to HU.
Conditions
- Essential Thrombocythemia
Interventions
Ropeginterferon alfa-2bBiological
Ropeginterferon alfa-2b (P1101) dosage: from 250 mcg to 500 mcg
AnagrelideDrug
Anagrelide dosage: 0.5 mg per capsule, according to label and physician's judgement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Peripheral blood count remissionTime frame: month 9 and month 12
- Improvement or non-progression in disease-related signsTime frame: month 9 and month 12
- Large symptoms improvement or maintain non-progressionTime frame: month 9 and month 12
- Absence of hemorrhagic or thrombotic eventsTime frame: month 9 and month 12
Locations
67 sites in 8 countries. Site status is shown where the registry gives one.
Mayo Clinic - Scottsdale
Scottsdale, Arizona
Washington University School of Medicine - Division of Oncology
St Louis, Missouri
MD Anderson Cancer Center
Houston, Texas
University of Utah
Salt Lake City, Utah
St. Paul's Hospital
Vancouver, British Columbia, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China
NanFang Hospital of Southern Medical University
Guangzhou, Guangdong, China
Union Hospital Tongji Medical College Huazhong University of Science and Technolog
Wuhan, Hubei, China
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Shaanxi Provincial People's Hospital
Xi'an, Shaanxi, China
Qilu Hospital of Shandong University
Jinan, Shandong, China
Ruijin Hospital affiliated to Shanghai Jiao Tong University school of Medicine
Shanghai, Shanghai Municipality, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
The Second Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital, College of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Queen Mary Hospital
Hong Kong, Hong Kong
Ehime University Hospital
Tōon, Ehime, Japan
Kitasato University Hospital
Sagamihara, Kanagawa, Japan
Mie University Hospital
Tsu, Mie-ken, Japan
University of Miyazaki Hospital
Miyazaki, Miyazaki, Japan
Kansai Medical University Hospital
Hirakata, Osaka, Japan
Kindai University Hospital
Sayama, Osaka, Japan
Osaka University Hospital
Suita, Osaka, Japan
Juntendo University Shizuoka Hospital
Izunokuni, Shizuoka, Japan
Juntendo University Hospital
Bunkyo City, Tokyo, Japan
Nippon Medical School Hospital
Bunkyo City, Tokyo, Japan
NTT Medical Center Tokyo
Shinagawa City, Tokyo, Japan
Tokyo Medical University Hospital
Shinjuku, Tokyo, Japan
University of Yamanashi Hospital
Chūō, Yamanashi, Japan
National University Hospital
Singapore, Singapore
Singapore General Hospital
Singapore, Singapore
Daegu Catholic University Hospital
Daegu, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.